Evidence map›Paper›PMID 28468878›Full record

ArticleJournal of virology2017

Cell Culture Systems To Study Human Herpesvirus 6A/B Chromosomal Integration.

Annie Gravel, Isabelle Dubuc, Nina Wallaschek, Shella Gilbert-Girard, Vanessa Collin, Ruth Hall-Sedlak, Keith R Jerome, Yasuko Mori, Julie Carbonneau, Guy Boivin and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Annie GravelDivision of Infectious and Immune Diseases, CHU de Quebec Research Center, Quebec City, Canada.
Isabelle DubucDivision of Infectious and Immune Diseases, CHU de Quebec Research Center, Quebec City, Canada.
Nina WallaschekInstitut für Virologie, Freie Universität Berlin, Berlin, Germany.
Shella Gilbert-GirardDivision of Infectious and Immune Diseases, CHU de Quebec Research Center, Quebec City, Canada.
Vanessa CollinDivision of Infectious and Immune Diseases, CHU de Quebec Research Center, Quebec City, Canada.
Ruth Hall-SedlakVirology Division, Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Keith R JeromeVirology Division, Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Yasuko MoriDivision of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Julie CarbonneauDivision of Infectious and Immune Diseases, CHU de Quebec Research Center, Quebec City, Canada.
Guy BoivinDivision of Infectious and Immune Diseases, CHU de Quebec Research Center, Quebec City, Canada.
Benedikt B KauferInstitut für Virologie, Freie Universität Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-1328-2695
Louis FlamandDivision of Infectious and Immune Diseases, CHU de Quebec Research Center, Quebec City, Canada louis.flamand@crchul.ulaval.ca.ORCID http://orcid.org/0000-0001-5010-4586
Centre hospitalier universitaire de Québec · CAFreie Universität Berlin · DEUniversity of Washington · USKobe University · JP

Funding

CIHR MOP_123214
6 · The paper itself

Abstract

Human herpesviruses 6A/B (HHV-6A/B) can integrate their viral genomes in the telomeres of human chromosomes. The viral and cellular factors contributing to HHV-6A/B integration remain largely unknown, mostly due to the lack of efficient and reproducible cell culture models to study HHV-6A/B integration. In this study, we characterized the HHV-6A/B integration efficiencies in several human cell lines using two different approaches. First, after a short-term infection (5 h), cells were processed for single-cell cloning and analyzed for chromosomally integrated HHV-6A/B (ciHHV-6A/B). Second, cells were infected with HHV-6A/B and allowed to grow in bulk for 4 weeks or longer and then analyzed for the presence of ciHHV-6. Using quantitative PCR (qPCR), droplet digital PCR, and fluorescent

Indexed as

Virus IntegrationCell Culture TechniquesCell LineHerpesvirus 6, HumanHumansIn Situ Hybridization, FluorescenceReal-Time Polymerase Chain ReactionVirus Cultivationchromosomal integrationddPCRHHV-6telomere

Identifiers

PMID28468878
PMCPMC5487542
OpenAlexW2611442212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.